All treatments
Treatment
SEL120 monohydrochloride, SEL120 monohydrochloride clinical trials
3 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
An Open-label, Single Agent, Phase I/II Trial Investigating the Safety and Efficacy of RVU120 (SEL120) in Patients with Relapsed / Refractory Metastatic or Advanced Solid Tumors
This study is testing a new medicine called RVU120 for people with advanced cancer that has come back or spread. Doctors want to see if it's safe, what dose works best, and if it helps shrink tumours or slow down the cancer's growth.
For: Relapsed / Refractory Metastatic or Advanced Solid TumorsSpain · Poland - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Multicenter, Open-Label Clinical Trial of RVU120 in Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia with or without NPM1 Mutation (RIVER-52)
This study is looking at a new drug, RVU120, for adults with specific types of blood cancer that have come back or not responded to previous treatments. It aims to see how well the drug works to put the cancer into remission.
For: Relapsed or Refractory High-Risk Myelodysplastic Syndrome, Acute Myeloid Leukemia with or without NPM1 MutationItaly · Poland · France - Ongoing, recruitingTherapeutic exploratory (Phase II)
A phase II, open-label, multicenter study of orally administered RVU120 for the treatment of anemia in patients with lower-risk myelodysplastic neoplasms (MDS)
This study is testing a new drug, RVU120, for people with a type of bone marrow problem called myelodysplastic neoplasms (MDS) who also have anaemia (low red blood cells). It looks at how well the drug helps the body make more red blood cells.
For: Anemia in patients with very low, low or intermediate risk myelodysplastic neoplasms (MDS)France · Italy · Germany